4.7 Article

A selective role of NKG2D in inflammatory and autoimmune diseases

期刊

CLINICAL IMMUNOLOGY
卷 149, 期 3, 页码 432-439

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2013.09.003

关键词

NKG2D; NK cells; EAE; NOD; Type 1 diabetes; Intestinal inflammation

资金

  1. Novo Nordisk, SA
  2. National Institutes of Health

向作者/读者索取更多资源

The NKG2D activating receptor has been implicated in numerous autoimmune diseases. We tested the role of NKG2D in models of autoimmunity and inflammation using NKG2D knockout mice and antibody blockade experiments. The severity of experimental autoimmune encephalitis (EAE) was decreased in NKG2D-deficient mice when the disease was induced with a limiting antigen dose, but unchanged with an optimal antigen dose. Surprisingly, however, NKG2D deficiency had no detectable effect in several other models, including two models of type 1 diabetes, and a model of intestinal inflammation induced by poly(I:C). NKG2D antibody blockade in normal mice also failed to inhibit disease in the NOD diabetes model or the intestinal inflammation model. Published evidence using NKG2D knockout mice demonstrated a role for NKG2D in mouse models of atherosclerosis and liver inflammation, as well as in chronic obstructive pulmonary disease. Therefore, our results suggest that NKG2D plays selective roles in inflammatory diseases. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Oncology

Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors

Michele Ardolino, David H. Raulet

ONCOIMMUNOLOGY (2016)

Review Immunology

Immunosurveillance and immunotherapy of tumors by innate immune cells

Alexandre Iannello, Thornton W. Thompson, Michele Ardolino, Assaf Marcus, David H. Raulet

CURRENT OPINION IN IMMUNOLOGY (2016)

Article Immunology

Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness

Nataliya Tovbis Shifrin, Djem U. Kissiov, Michele Ardolino, Nathalie T. Joncker, David H. Raulet

JOURNAL OF IMMUNOLOGY (2016)

Article Oncology

Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells

Asaf Spiegel, Mary W. Brooks, Samin Houshyar, Ferenc Reinhardt, Michele Ardolino, Evelyn Fessler, Michelle B. Chen, Jordan A. Krall, Jasmine DeCock, Ioannis K. Zervantonakis, Alexandre Iannello, Yoshiko Iwamoto, Virna Cortez-Retamozo, Roger D. Kamm, Mikael J. Pittet, David H. Raulet, Robert A. Weinberg

CANCER DISCOVERY (2016)

Article Oncology

Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies

Joanne Xiu, David Piccioni, Tiffany Juarez, Sandeep C. Pingle, Jethro Hu, Jeremy Rudnick, Karen Fink, David B. Spetzler, Todd Maney, Anatole Ghazalpour, Ryan Bender, Zoran Gatalica, Sandeep Reddy, Nader Sanai, Ahmed Idbaih, Michael Glantz, Santosh Kesari

ONCOTARGET (2016)

Letter Immunology

Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells

Yann M. Kerdiles, Francisca F. Almeida, Thornton Thompson, Michael Chopin, Margaux Vienne, Pierre Bruhns, Nicholas D. Huntington, David H. Raulet, Stephen L. Nutt, Gabrielle T. Belz, Eric Vivier

IMMUNITY (2017)

Article Oncology

MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions

Amanda R. Campbell, Megan C. Duggan, Lorena P. Suarez-Kelly, Neela Bhave, Kallan S. Opheim, Elizabeth L. McMichael, Prashant Trikha, Robin Parihar, Eric Luedke, Adrian Lewis, Bryant Yung, Robert Lee, David Raulet, Susheela Tridandapani, Veronika Groh, Lianbo Yu, Vedat Yildiz, John C. Byrd, Michael A. Caligiuri, William E. Carson

CANCER IMMUNOLOGY RESEARCH (2017)

Article Biochemistry & Molecular Biology

In vitro-transcribed guide RNAs trigger an innate immune response via the RIG-I pathway

Beeke Wienert, Jiyung Shin, Elena Zelin, Kathleen Pestal, Jacob E. Corn

PLOS BIOLOGY (2018)

Letter Biotechnology & Applied Microbiology

Blueprint for a pop-up SARS-CoV-2 testing lab

Alexandra M. Amen, Alexandra M. Amen, Kerrie W. Barry, John M. Boyle, Cara E. Brook, Seunga Choo, L. T. Cornmesser, David J. Dilworth, Jennifer A. Doudna, Alexander J. Ehrenberg, Indro Fedrigo, Skyler E. Friedline, Thomas G. W. Graham, Ralph Green, Jennifer R. Hamilton, Ariana Hirsh, Megan L. Hochstrasser, Dirk Hockemeyer, Netravathi Krishnappa, Azra Lari, Hanqin Li, Enrique Lin-Shiao, Tianlin Lu, Elijah F. Lyons, Kevin G. Mark, Lisa Argento Martell, A. Raquel O. Martins, Shana L. McDevitt, Patrick S. Mitchell, Erica A. Moehle, Christine Naca, Divya Nandakumar, Elizabeth O'Brien, Derek J. Pappas, Kathleen Pestal, Diana L. Quach, Benjamin E. Rubin, Rohan Sachdeva, Elizabeth C. Stahl, Abdullah Muhammad Syed, I-Li Tan, Amy L. Tollner, Connor A. Tsuchida, C. Kimberly Tsui, Timothy K. Turkalo, Fyodor D. Urnov, M. Bryan Warf, Oscar N. Whitney, Lea B. Witkowsky

NATURE BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples

Jennifer R. Hamilton, Elizabeth C. Stahl, Connor A. Tsuchida, Enrique Lin-Shiao, C. Kimberly Tsui, Kathleen Pestal, Holly K. Gildea, Lea B. Witkowsky, Erica A. Moehle, Shana L. McDevitt, Matthew McElroy, Amanda Keller, Iman Sylvain, Ariana Hirsh, Alison Ciling, Alexander J. Ehrenberg, Bradley R. Ringeisen, Garth Huberty, Fyodor D. Urnov, Petros Giannikopoulos, Jennifer A. Doudna

Summary: This study developed a robotic nucleic acid extraction method for high-throughput detection of SARS-CoV-2 RNA in saliva samples. The research identified rare positive specimens containing SARS-CoV-2 RNA during a time of low infection prevalence when testing supervised self-collected saliva samples.

PLOS ONE (2021)

Review Oncology

A Systems Approach to Brain Tumor Treatment

James H. Park, Adrian Lopez Garcia de Lomana, Diego M. Marzese, Tiffany Juarez, Abdullah Feroze, Parvinder Hothi, Charles Cobbs, Anoop P. Patel, Santosh Kesari, Sui Huang, Nitin S. Baliga

Summary: Pronounced differences between individuals and cell-cell heterogeneity within tumors are major obstacles in effective brain tumor treatment, necessitating a personalized precision medicine approach. A systems biology approach is crucial for developing a multiscale understanding of disease mechanisms. Integrating patient tumor analysis with clinical medicine can optimize treatment strategies.

CANCERS (2021)

Article Medicine, General & Internal

Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001

Terese Catherine Hammond, Raymond C. Lee, Bryan Oronsky, Tony R. Reid, Scott Caroen, Tiffany M. Juarez, Jaya Gill, Annie Heng, Santosh Kesari

Summary: This article presents the first report of RRx-001 treatment for COVID-19. Two critically ill patients with COVID-19, who had tried all available treatment options, showed improvement after receiving RRx-001. RRx-001 is a first-in-class small molecule with various properties and has been safely administered to over 300 patients in clinical trials.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2022)

Review Immunology

Regulation of the nucleic acid-sensing Toll-like receptors

Nicholas A. Lind, Victoria E. Rael, Kathleen Pestal, Bo Liu, Gregory M. Barton

Summary: Activation of nucleic acid-sensing Toll-like receptors is finely tuned to distinguish between self and foreign nucleic acids. The ligands for TLRs are mostly unique to microorganisms, but a subset can recognize nucleic acids present in both host and foreign microorganisms, potentially leading to self-recognition and autoimmune diseases. Research in defining the regulatory mechanisms for proper discrimination between foreign and self-nucleic acids by TLRs has revealed a complex array of mechanisms, categorized into compartmentalization, ligand availability, receptor expression, and signal transduction.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Immunology

The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity

Jacquelyn A. Gorman, Christian Hundhausen, John S. Errett, Amy E. Stone, Eric J. Allenspach, Yan Ge, Tanvi Arkatkar, Courtnee Clough, Xuezhi Dai, Socheath Khim, Kathleen Pestal, Denny Liggitt, Karen Cerosaletti, Daniel B. Stetson, Richard G. James, Mohamed Oukka, Patrick Concannon, Michael Gale, Jane H. Buckner, David J. Rawlings

NATURE IMMUNOLOGY (2017)

暂无数据